Clinical trial investigates Alzheimer's disease drug in people with Down syndrome

Clinical trial investigates Alzheimer's disease drug in people with Down syndrome:

Dementia Big
A phase 2 clinical trial in young adults with Down syndrome of a drug being investigated for the treatment of Alzheimer’s disease supports further investigation of its potential. Results of the four-week trial of scyllo-inositol, also known as ELND005, have been published in the Journal of Alzheimer’s Disease.

http://ift.tt/2sgBnm6